Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at a high risk of VTE recurrence and bleeding during�…

Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at an increased risk of developing VTE and are more likely to�…

Abstract In 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical
guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in�…

Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and�…

Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment�…

Background: Guidelines addressing the management of venous thromboembolism (VTE) in
cancer patients are heterogeneous and their implementation has been suboptimal�…

PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the�…

Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity
and mortality. VTE prevention and treatment are more complex in patients with cancer. The�…

Anticoagulation for the long‐term treatment of venous thromboembolism in patients with cancer
- Akl, EA - 2014 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve�…

Background Venous thromboembolism (VTE) often complicates the clinical course of
cancer. The risk is further increased by chemotherapy, but the trade‐off between safety and�…